共 50 条
- [21] PHASE I CLINICAL TRIAL OF PEPOSERTIB PLUS RADIOTHERAPY IN ADULTS WITH NEWLY-DIAGNOSED MGMT-UNMETHYLATED GLIOBLASTOMANEURO-ONCOLOGY, 2024, 26Majd, NazaninLiu, JohnYeboa, NanaWang, ShuqiWeathers, Shiao-PeiYuan, YingGachimova, EvgueniaWathoo, ChetnaKamiya-Matsuoka, CarlosO'Brien, BarbaraAaroe, AshleyPatel, ChiragPatel, AnujDagher, SamirWintermark, MaxFerguson, SherisePuduvalli, VinayRaleigh, Davidde Groot, John
- [22] Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trialNEURO-ONCOLOGY, 2023, 25 (01) : 123 - 134Omuro, AntonioBrandes, Alba A.Carpentier, Antoine F.Idbaih, AhmedReardon, David A.Cloughesy, TimothySumrall, AshleyBaehring, Joachimvan den Bent, MartinBahr, OliverLombardi, GiuseppeMulholland, PaulTabatabai, GhazalehLassen, UlrikSepulveda, Juan ManuelKhasraw, MustafaVauleon, ElodieMuragaki, YoshihiroDi Giacomo, Anna MariaButowski, NicholasRoth, PatrickQian, XiaozhongFu, Alex Z.Liu, YanfangPotter, VonChalamandaris, Alexandros-GeorgiosTatsuoka, KayLim, MichaelWeller, Michael
- [23] Phase 1 dose-finding study to evaluate safety and tolerability of CVGBM in patients with newly diagnosed and surgically resected MGMT-unmethylated glioblastoma.JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Tabatabai, GhazalehVon Baumgarten, LouisaVan Den Bent, Martin J.Burger, Michael C.Freres, PierreGlas, MartinHau, PeterHerrlinger, UlrichMildenberger, IrisNeyns, BartSchafer, Henning SebastianSeidel, ClemensGalot, RachelWick, AntjeFalk, Martin H.Chama, Laura Leticia de FreitasKelemen, PeterKoch, Sven D.Roche, Paula RomerGnad-Vogt, Senta Ulrike
- [24] PHASE II TRIAL OF A SURVIVIN VACCINE (SurVaxM) FOR NEWLY DIAGNOSED GLIOBLASTOMANEURO-ONCOLOGY, 2018, 20 : 10 - 11Ahluwalia, ManmeetReardon, DavidAbad, AjayCurry, WilliamWong, EricPeereboom, DavidBelal, AhmedQiu, JingxinMogensen, KathleenSchilero, CathyCasucci, DanielleMechtler, LaszloUhlmann, ErikCiesielski, MichaelFenstermaker, Robert
- [25] PHASE 2 STUDY OF VAL-083 AND RADIOTHERAPY IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBMNEURO-ONCOLOGY, 2022, 24 : 78 - 78Chen, ZhongPingGuo, ChengchengChen, JianGen
- [26] PHASE 2 STUDY OF VAL-083 AND RADIOTHERAPY IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBMNEURO-ONCOLOGY, 2021, 23 : 63 - 64Chen, Zhong-pingGuo, Cheng-ChengYang Qun-yingLi, Jia-WeiWu, Shao-xiongBacha, JeffreyJohnson, GregoryLanglands, JohnKwan, ClaireKanekal, SarathSchwartz, RichardSteino, AnneBrown, Dennis
- [27] Benefits of Interferon-β and Temozolomide Combination Therapy for Newly Diagnosed Primary Glioblastoma With the Unmethylated MGMT Promoter A Multicenter StudyCANCER, 2011, 117 (08) : 1721 - 1730Motomura, KazuyaNatsume, AtsushiKishida, YugoHigashi, HiroyukiKondo, YutakaNakasu, YokoAbe, TatsuyaNamba, HirokiWakai, KenjiWakabayashi, Toshihiko
- [28] Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE studyNEURO-ONCOLOGY, 2015, 17 (05) : 708 - 717Nabors, L. BurtFink, Karen L.Mikkelsen, TomGrujicic, DanicaTarnawski, RafalNam, Do HyunMazurkiewicz, MariaSalacz, MichaelAshby, LynnZagonel, VittorinaDepenni, RobertaPerry, James R.Hicking, ChristinePicard, MartinHegi, Monika E.Lhermitte, BenoitReardon, David A.
- [29] CC-115 IN NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA IN THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT): A PHASE II RANDOMIZED BAYESIAN ADAPTIVE PLATFORM TRIALNEURO-ONCOLOGY, 2020, 22 : 43 - 44Rahman, RifaquatTrippa, LorenzoFell, GeoffreyLee, EudociaArrillaga-Romany, IsabelTouat, MehdiMcCluskey, ChristineBrunno, JenniferGaffey, SarahDrappatz, JanLassman, AndrewGalanis, EvanthiaAhluwalia, ManmeetColman, HowardNabors, LouisHepel, JaroslawElinzano, HeinrichSchiff, DavidChukwueke, UgonmaBeroukhim, RameenNayak, LakshmiMcfaline-Figueroa, JoseBatchelor, TracyRinne, MikaelKaley, ThomasLu-Emerson, ChristineBi, Wenya LindaArnaout, OmarHaas-Kogan, DaphneTanguturi, ShyamCagney, DanielAizer, Ayal A.Welch, MaryDoherty, LisaLavallee, MariaFisher-Longden, BrittanyDowling, ShannaGeduldig, JackWatkinson, FionaSantagata, SandroMeredith, DavidChiocca, E. AntonioReardon, DavidLigon, KeithAlexander, BrianWen, Patrick
- [30] TRIAL IN PROGRESS: PHASE 1 DOSE-FINDING STUDY TO EVALUATE SAFETY AND TOLERABILITY OF CVGBM IN PATIENTS WITH NEWLY DIAGNOSED AND SURGICALLY RESECTED MGMT-UNMETHYLATED GLIOBLASTOMANEURO-ONCOLOGY, 2023, 25 : 47 - 47Tabatabai, G.von Baumgarten, L.van den Bent, M.Burger, M. C.Freres, P.Glas, M.Hau, P.Herrlinger, U.Mildenberger, I.Neyns, B.Schaefer, H.Seidel, C.de Vos, F.Galot, R.Whenham, N.Wick, A.Falk, M.Chama, L. de FreitasHenze, J.Kelemen, P.Koch, S. D.Lutz, J.Heidenreich, R.Roche, P. RomerRost, T.Schoenborn-Kellenberger, O.Gnad-Vogt, U.